Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Baker

Showing results (41-50 of 1,276) with videos related to

Pageof 128
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Automated de novo prediction of native-like RNA tertiary structuresRhiju Das, David Baker
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Quality control of experimental autoimmune encephalomyelitisDavid Baker, Sandra Amor
Proteins|October 13, 2006
Improved beta-protein structure prediction by multilevel optimization of nonlocal strand pairings and local backbone conformationPhilip Bradley, David Baker
Acta Crystallographica. Section D, Biological Crystallography|January 28, 2009
Prospects for de novo phasing with de novo protein modelsRhiju Das, David Baker
CNS & Neurological Disorders Drug Targets|May 16, 2012
Optical coherence tomography detection of neurodegeneration in multiple sclerosisKatie Lidster, David Baker
CNS & Neurological Disorders Drug Targets|May 16, 2012
Potential control of multiple sclerosis by cannabis and the endocannabinoid systemGareth Pryce, David Baker
Journal of the Neurological Sciences|July 20, 2019
Cost of disease modifying therapies for multiple sclerosis: Is front-loading the answer?Lisa Batcheller, David Baker
Brain Pathology (Zurich, Switzerland)|April 15, 2020
B cells and multiple sclerosis spinal cord pathologyKlaus Schmierer, David Baker
Protein Science : a Publication of the Protein Society|July 20, 2012
Comparison of designed and randomly generated catalysts for simple chemical reactionsYakov Kipnis, David Baker
Multiple Sclerosis and Related Disorders|August 13, 2015
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wiselyDavid Baker, Sandra Amor
Pageof 128

Showing results (41-50 of 1,276) with videos related to

Sort By:
Pageof 128
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2007
Automated de novo prediction of native-like RNA tertiary structuresRhiju Das, David Baker
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2010
Quality control of experimental autoimmune encephalomyelitisDavid Baker, Sandra Amor
Proteins|October 13, 2006
Improved beta-protein structure prediction by multilevel optimization of nonlocal strand pairings and local backbone conformationPhilip Bradley, David Baker
Acta Crystallographica. Section D, Biological Crystallography|January 28, 2009
Prospects for de novo phasing with de novo protein modelsRhiju Das, David Baker
CNS & Neurological Disorders Drug Targets|May 16, 2012
Optical coherence tomography detection of neurodegeneration in multiple sclerosisKatie Lidster, David Baker
CNS & Neurological Disorders Drug Targets|May 16, 2012
Potential control of multiple sclerosis by cannabis and the endocannabinoid systemGareth Pryce, David Baker
Journal of the Neurological Sciences|July 20, 2019
Cost of disease modifying therapies for multiple sclerosis: Is front-loading the answer?Lisa Batcheller, David Baker
Brain Pathology (Zurich, Switzerland)|April 15, 2020
B cells and multiple sclerosis spinal cord pathologyKlaus Schmierer, David Baker
Protein Science : a Publication of the Protein Society|July 20, 2012
Comparison of designed and randomly generated catalysts for simple chemical reactionsYakov Kipnis, David Baker
Multiple Sclerosis and Related Disorders|August 13, 2015
Experimental autoimmune encephalomyelitis is a good model of multiple sclerosis if used wiselyDavid Baker, Sandra Amor
Pageof 128